Skip to main content
. 2016 Aug;114:T2.

TABLE 10.

PROPORTION OF PATIENTS WITH VISUAL ACUITY OF 20/40 OR BETTER, BY BASELINE VISUAL ACUITY (SMALL/MEDIUM TUMORS)

BLVA 20/40 OR BETTER BLVA WORSE THAN 20/40

Time post Tx RBZ+
PBI
(%)
PBI
(%)
P* RBZ+
PBI
(%)
PBI
(%)
P*
12 months 19/22 (86.4) 44/53 (83.0) .51 1/2 (50.0) 3/18 (16.7) .37
24 months 20/22 (90.9) 26/44 (59.1) .007 1/2 (50.0) 8/26 (30.8) .55
*

Fisher’s exact test

BLVA: baseline visual acuity; Tx:treatment; RBZ: ranibizumab; PBI: proton beam irradiation